S I D E B A R
Format
Items per page
Sort by

Download:

Choose Destination

Search results

Items: 1 to 100 of 1621

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review statusAccession
1.
PTEN, ZIC2Neurodevelopmental disorderLikely pathogenic
(Apr 9, 2019)
no assertion criteria providedVCV000635927
2.
PTENPTEN hamartoma tumor syndromePathogenic
(Dec 8, 2015)
criteria provided, single submitterVCV000254038
3.
PTENHereditary cancer-predisposing syndromeUncertain significance
(Dec 16, 2013)
criteria provided, single submitterVCV000127658
4.
PTENHereditary cancer-predisposing syndromeUncertain significance
(Dec 31, 2013)
criteria provided, single submitterVCV000127656
5.
PTENMacrocephaly/autism syndromePathogenic
(Mar 15, 2007)
no assertion criteria providedVCV000007851
6.
PTENCowden syndrome 1Pathogenic
(Jul 15, 2003)
no assertion criteria providedVCV000007847
7.
PTENCowden syndrome 1Pathogenic
(Aug 1, 2003)
no assertion criteria providedVCV000007846
8.
PTENC124SCowden syndrome 1Pathogenic
(Mar 15, 2001)
no assertion criteria providedVCV000007835
9.
GRCh37:
Chr10:42347406-135534747
ACADSB, ACTA2, ADAM8, ADD3, ADK, ADRA2A, ADRB1, ALOX5, ANK3, ANXA7, ANXA11, FAS, ARL3, CHAT, BMPR1A, BNIP3, CAMK2G, CASP7, ENTPD1, CDK1, CHUK, ABCC2, COL13A1, COL17A1, COX15, CPN1, CTBP2, CYP2C19, CYP2C8, CYP2C9, CYP2C18, CYP2E1, CYP17A1, CYP26A1, DMBT1, DNA2, DNTT, DOCK1, DUSP5, ECHS1, EGR2, EIF4EBP2, EMX2, ERCC6, FGF8, FGFR2, GDF2, GDF10, GFRA1, GLUD1, GOT1, PRLHR, GPR26, GRK5, GRID1, HABP2, HELLS, HHEX, HK1, HMX2, HNRNPF, HNRNPH3, TLX1, HPS1, HTR7, IDE, IFIT2, IFIT1, IFIT3, INPP5A, KCNMA1, KIF11, ABLIM1, LIPA, MAT1A, MBL2, MGMT, MKI67, MSMB, MXI1, NDUFB8, NFKB2, NODAL, NRAP, OAT, P4HA1, PAX2, PCBD1, PDE6C, PGAM1, PITX3, PLAU, PNLIP, PNLIPRP1, PNLIPRP2, PPA1, PPP1R3C, PPP3CB, NPY4R, PRF1, SRGN, PRKG1, MAPK8, HTRA1, PSAP, PSD, PTEN, PTPRE, ALDH18A1, RBP3, RBP4, RET, RGR, RGS10, RPS24, SCD, CXCL12, SFRP5, SFTPD, FBXW4, SLC18A2, SLC18A3, SLIT1, SNCG, SUPV3L1, TACR2, TAF5, TCF7L2, TECTB, TFAM, TIAL1, TLL2, UBE2D1, UROS, VCL, VDAC2, WNT8B, XPNPEP1, ZNF22, ZNF32, ZNF33B, CCDC6, NCOA4, SLC25A16, SHOC2, ADAM12, ZNF239, UTF1, PARG, NDST2, LIPF, EIF3A, GBF1, LDB1, SGPL1, BTRC, CH25H, PKD2L1, BTAF1, PAPSS2, INA, PDLIM1, SMC3, NEURL1, BUB3, DDX21, LGI1, NOLC1, DLG5, GSTO1, CHST3, BAG3, VPS26A, MINPP1, KIF20B, SEC24C, SH3PXD2A, FAM53B, GPRIN2, SLK, BMS1, SPOCK2, ZNF518A, RHOBTB1, DCLRE1A, FRAT1, PPIF, ACTR1A, SMNDC1, NPM3, MICU1, GLRX3, RPP30, DPYSL4, TACC2, SORBS1, ERLIN1, LBX1, NRG3, OGA, TUBGCP2, PRDX3, ADIRF, VAX1, DEPP1, ATE1, POLR3A, ZWINT, LDB3, SEC23IP, ECD, RAB11FIP2, CPEB3, INPP5F, ZNF365, DKK1, NT5C2, PDCD11, SORCS3, ZSWIM8, WAPL, PPRC1, ABRAXAS2, RRP12, TBC1D12, DNAJC9, DNMBP, CSTF2T, FRAT2, SIRT1, KAT6B, TSPAN15, IFIT5, DPCD, SEC31B, NUDT13, ATRNL1, HERC4, PTPN20, EDRF1, LRIT1, TCTN3, KIFBP, C10orf12, ANKRD2, CNNM1, MYOF, AP3M1, ANKRD1, GHITM, PALD1, PDCD4, VENTX, R3HCC1L, POLL, CTNNA3, BLNK, A1CF, NRBF2, KCNIP2, CUZD1, CALY, NEUROG3, ASCC1, EXOSC1, MRPS16, CALHM2, CUTC, PLCE1, DUSP13, CHST15, SUFU, ACSL5, PANK1, FXYD4, CCSER2, EXOC6, SHLD2, DDIT4, CCNJ, MARCHF5, ZRANB1, CFAP46, NSMCE4A, DNAJB12, CNNM2, WBP1L, CCDC186, CRTAC1, CEP55, LRRC20, CWF19L1, SLC29A3, RNLS, PI4K2A, CSGALNACT2, MACROH2A2, HIF1AN, RUFY2, WDR11, SLF2, CCAR1, OGDHL, DHX32, PPP2R2D, CISD1, TDRD1, DNAJC12, ASAH2, BCCIP, TWNK, SAR1A, TM9SF3, ENTPD7, ZMIZ1, AS3MT, STAMBPL1, GPAM, SHTN1, FAM160B1, WDFY4, SEMA4G, ARHGAP22, MYOZ1, PLEKHA1, AVPI1, HPSE2, FAM204A, CDH23, LHPP, PBLD, NPFFR1, VSIR, MMS19, NOC3L, IKZF5, ZDHHC6, PCDH15, CUEDC2, DDX50, FBXL15, OR13A1, ARMH3, HPS6, MMRN2, MFSD13A, MCMBP, SYNPO2L, C10orf95, PLEKHS1, PDZD7, STN1, C10orf88, UBTD1, BICC1, TMEM254, HKDC1, CFAP43, TET1, LRRC27, TNKS2, TRIM8, TSPAN14, KAZALD1, SFXN3, SLC25A28, ELOVL3, MARVELD1, SYT15, RASSF4, LRMDA, PCGF6, ARID5B, LOXL4, ZDHHC16, PRXL2A, DYDC2, PCGF5, ADGRA1, LZTS2, PHYHIPL, LCOR, NKX6-2, MRPL43, AFAP1L2, PLA2G12B, MYPN, PYROXD2, ATP5MD, ZNF503, AIFM2, ADO, ATAD1, ARHGAP19, KNDC1, ITPRIP, MCU, MTG1, CDHR1, BBIP1, FANK1, OPALIN, SYCE1, ZFAND4, OPN4, HOGA1, SORCS1, C10orf71, PRAP1, ZNF511, CHCHD1, MSS51, CFAP70, C10orf90, BTBD16, FAM24A, PSTK, ZNF488, PIK3AP1, MORN4, ZFYVE27, MMP21, COMTD1, FRA10AC1, ANKRD22, SFXN2, PDZD8, AGAP4, BORCS7, AGAP11, GSTO2, SFR1, CALHM3, CLRN3, ANAPC16, PNLIPRP3, SFXN4, CPXM2, ADAMTS14, ACSM6, SAMD8, LIPJ, TRUB1, FRMPD2, VTI1A, DYDC1, EIF5AL1, HECTD2, FGFBP3, C10orf82, CACUL1, USP54, NKX2-3, SLC35G1, CFAP58, FAM170B, TMEM273, FUT11, OIT3, C10orf91, PWWP2B, EMX2OS, PLPP4, VSTM4, PAOX, FAM24B, PLAC9, CABCOCO1, TMEM26, ZCCHC24, UNC5B, STOX1, FAM241B, TYSND1, RTKN2, TBATA, ATOH7, SLC16A9, FAM13C, MARCHF8, C10orf25, ZNF485, RASGEF1A, REEP3, JMJD1C, IPMK, WASHC2C, EBF3, CALHM1, CASC2, TCERG1L, HSPA12A, SGMS1, PGBD3, C10orf53, FUOM, JAKMIP3, STK32C, BLOC1S2, RBM20, FAM149B1, FFAR4, KCNK18, DUPD1, LIPM, CYP26C1, VWA2, NANOS1, LRIT2, HMX3, LRRTM3, NHLRC2, CCDC172, WASHC2A, SH2D4B, C10orf99, SLC16A12, CC2D2B, ENO4, ARMS2, TEX36, NKX1-2, C10orf120, EEF1AKMT2, FOXI2, GOLGA7B, DENND10, MIR107, C10orf105, C10orf62, AGAP6, C10orf55, IFIT1B, FRG2B, MIR346, LRRC18, SPRN, MIR146B, NPS, AGAP9, INSYN2A, FAM25A, TMEM72, LIPK, LIPN, FAM25E, FAM25C, DRGX, ANXA8, ASAH2B, SFTPA1, SNORA12, ANXA8L1, NUTM2A, AGAP10, AGAP5, SFTPA2, NUTM2B, TLX1NB, C10orf131, LOC100131132, FAM25G, ADIRF-AS1, KLLN, TIMM23, FAS-AS1, MTRNR2L5, TCERG1L-AS1, LINC01166, LOC101929662, LINC01520
PARP Inhibitor responsedrug response
(Nov 27, 2017)
no assertion criteria providedVCV000523165
10.
GRCh37:
Chr10:85557432-105804295
LINC01520, ACTA2, FAS, ARL3, BMPR1A, ENTPD1, CHUK, ABCC2, COL17A1, COX15, CPN1, CYP2C19, CYP2C8, CYP2C9, CYP2C18, CYP17A1, CYP26A1, DNTT, FGF8, GLUD1, GOT1, GRID1, HELLS, HHEX, TLX1, HPS1, HTR7, IDE, IFIT2, IFIT1, IFIT3, KIF11, LIPA, NDUFB8, NFKB2, PAX2, PDE6C, PGAM1, PITX3, PPP1R3C, PSD, PTEN, ALDH18A1, RBP4, RGR, SCD, SFRP5, FBXW4, SLIT1, SNCG, TAF5, TLL2, WNT8B, LIPF, GBF1, LDB1, BTRC, CH25H, PKD2L1, BTAF1, PAPSS2, INA, PDLIM1, NEURL1, LGI1, NOLC1, MINPP1, KIF20B, SH3PXD2A, SLK, ZNF518A, FRAT1, ACTR1A, NPM3, RPP30, SORBS1, ERLIN1, LBX1, OGA, ADIRF, LDB3, CPEB3, NT5C2, PDCD11, WAPL, PPRC1, RRP12, TBC1D12, DNMBP, FRAT2, IFIT5, DPCD, SEC31B, LRIT1, TCTN3, C10orf12, ANKRD2, CNNM1, MYOF, ANKRD1, GHITM, R3HCC1L, POLL, BLNK, KCNIP2, EXOSC1, CALHM2, CUTC, PLCE1, SUFU, PANK1, CCSER2, EXOC6, SHLD2, CCNJ, MARCHF5, CNNM2, WBP1L, CRTAC1, CEP55, CWF19L1, RNLS, PI4K2A, HIF1AN, SLF2, TWNK, TM9SF3, ENTPD7, AS3MT, STAMBPL1, SEMA4G, AVPI1, HPSE2, MMS19, NOC3L, CUEDC2, FBXL15, ARMH3, HPS6, MMRN2, MFSD13A, C10orf95, PDZD7, STN1, UBTD1, TNKS2, TRIM8, KAZALD1, SFXN3, SLC25A28, ELOVL3, MARVELD1, PCGF6, LOXL4, ZDHHC16, PCGF5, LZTS2, LCOR, MRPL43, PYROXD2, ATP5MD, ATAD1, ARHGAP19, CDHR1, OPALIN, OPN4, HOGA1, PIK3AP1, MORN4, ZFYVE27, FRA10AC1, ANKRD22, SFXN2, BORCS7, AGAP11, CALHM3, ACSM6, LIPJ, HECTD2, FGFBP3, NKX2-3, SLC35G1, CALHM1, BLOC1S2, FFAR4, LIPM, CYP26C1, LRIT2, C10orf99, SLC16A12, CC2D2B, GOLGA7B, MIR107, C10orf62, IFIT1B, MIR346, MIR146B, FAM25A, LIPK, LIPN, SNORA12, NUTM2A, TLX1NB, C10orf131, ADIRF-AS1, KLLN, FAS-AS1, LOC101929662
PARP Inhibitor responsedrug response
(Nov 27, 2017)
no assertion criteria providedVCV000377387
11.
GRCh37:
Chr10:89590587-90376982
GRCh38:
Chr10:87830830-88617225
PTEN, RNLS, ATAD1, LIPJ, KLLNPARP Inhibitor responsedrug response
(Nov 27, 2017)
no assertion criteria providedVCV000523155
12.
GRCh37:
Chr10:89622885
GRCh38:
Chr10:87863128
PTEN, KLLNnot providedUncertain significance
(Jul 9, 2014)
criteria provided, single submitterVCV000189461
13.
GRCh37:
Chr10:89622888
GRCh38:
Chr10:87863131
PTEN, KLLNnot providedUncertain significance
(Aug 6, 2018)
criteria provided, multiple submitters, no conflictsVCV000488770
14.
GRCh37:
Chr10:89622891
GRCh38:
Chr10:87863134
PTEN, KLLNnot providedUncertain significance
(Dec 1, 2015)
criteria provided, single submitterVCV000488849
15.
GRCh37:
Chr10:89622896
GRCh38:
Chr10:87863139
PTEN, KLLNnot specifiedUncertain significance
(Mar 30, 2015)
criteria provided, single submitterVCV000503507
16.
GRCh37:
Chr10:89622902
GRCh38:
Chr10:87863145
PTEN, KLLNnot providedUncertain significance
(Dec 31, 2014)
criteria provided, single submitterVCV000503638
17.
GRCh37:
Chr10:89622905
GRCh38:
Chr10:87863148
PTEN, KLLNnot providedUncertain significance
(Jun 21, 2017)
criteria provided, single submitterVCV000488905
18.
GRCh37:
Chr10:89622915
GRCh38:
Chr10:87863158
PTEN, KLLNPTEN hamartoma tumor syndrome, not specified, not provided
Benign
(Jun 2, 2017)
reviewed by expert panel
FDA Recognized Database
VCV000127667
19.
GRCh37:
Chr10:89622916
GRCh38:
Chr10:87863159
PTEN, KLLNnot providedUncertain significance
(May 12, 2015)
criteria provided, single submitterVCV000488761
20.
GRCh37:
Chr10:89622919
GRCh38:
Chr10:87863162
KLLN, PTENnot providedUncertain significance
(Aug 16, 2016)
criteria provided, single submitterVCV000488860
21.
GRCh37:
Chr10:89622921
GRCh38:
Chr10:87863164
PTEN, KLLNnot specifiedUncertain significance
(Apr 28, 2017)
criteria provided, single submitterVCV000439287
22.
GRCh37:
Chr10:89622925
GRCh38:
Chr10:87863168
KLLN, PTENnot providedUncertain significance
(Mar 26, 2016)
criteria provided, single submitterVCV000488886
23.
GRCh37:
Chr10:89622928
GRCh38:
Chr10:87863171
PTEN, KLLNnot providedUncertain significance
(Oct 11, 2017)
criteria provided, single submitterVCV000488783
24.
GRCh37:
Chr10:89622931
GRCh38:
Chr10:87863174
PTEN, KLLNnot providedUncertain significance
(Oct 9, 2017)
criteria provided, single submitterVCV000488754
25.
GRCh37:
Chr10:89622933
GRCh38:
Chr10:87863176
PTEN, KLLNnot providedUncertain significance
(Sep 26, 2016)
criteria provided, single submitterVCV000488713
26.
GRCh37:
Chr10:89622936
GRCh38:
Chr10:87863179
PTEN, KLLNnot specifiedUncertain significance
(Oct 13, 2016)
criteria provided, single submitterVCV000234639
27.
GRCh37:
Chr10:89622939
GRCh38:
Chr10:87863182
PTEN, KLLNnot providedUncertain significance
(Jun 10, 2016)
criteria provided, single submitterVCV000488910
28.
GRCh37:
Chr10:89622939
GRCh38:
Chr10:87863182
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Sep 7, 2017)
criteria provided, single submitterVCV000141821
29.
GRCh37:
Chr10:89622945
GRCh38:
Chr10:87863188
PTEN, KLLNnot providedUncertain significance
(May 2, 2016)
criteria provided, single submitterVCV000488901
30.
GRCh37:
Chr10:89622951
GRCh38:
Chr10:87863194
PTEN, KLLNnot providedUncertain significance
(Aug 29, 2016)
criteria provided, single submitterVCV000488934
31.
GRCh37:
Chr10:89622960
GRCh38:
Chr10:87863203
PTEN, KLLNnot providedUncertain significance
(Jan 26, 2015)
criteria provided, single submitterVCV000503639
32.
GRCh37:
Chr10:89622964
GRCh38:
Chr10:87863207
PTEN, KLLNnot specifiedUncertain significanceno assertion criteria providedVCV000492717
33.
GRCh37:
Chr10:89622970
GRCh38:
Chr10:87863213
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Nov 16, 2013)
criteria provided, single submitterVCV000141062
34.
GRCh37:
Chr10:89622979
GRCh38:
Chr10:87863222
KLLN, PTENnot specifiedUncertain significance
(Jul 13, 2016)
criteria provided, single submitterVCV000189445
35.
GRCh37:
Chr10:89622980
GRCh38:
Chr10:87863223
PTEN, KLLNnot provided, Malignant tumor of prostate, VACTERL association with hydrocephalus,
PTEN hamartoma tumor syndrome, Glioma susceptibility 2, Macrocephaly/autism syndrome,
Meningioma, familial, Cowden syndrome 1
Uncertain significance
(Oct 31, 2018)
criteria provided, multiple submitters, no conflictsVCV000488964
36.
GRCh37:
Chr10:89622983
GRCh38:
Chr10:87863226
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Oct 13, 2017)
criteria provided, single submitterVCV000127666
37.
GRCh37:
Chr10:89622986
GRCh38:
Chr10:87863229
PTEN, KLLNnot providedUncertain significance
(Jul 28, 2015)
criteria provided, single submitterVCV000488776
38.
GRCh37:
Chr10:89622991
GRCh38:
Chr10:87863234
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Apr 23, 2018)
criteria provided, single submitterVCV000186644
39.
GRCh37:
Chr10:89622992
GRCh38:
Chr10:87863235
PTEN, KLLNnot specifiedUncertain significance
(Mar 10, 2016)
criteria provided, single submitterVCV000234894
40.
GRCh37:
Chr10:89622992
GRCh38:
Chr10:87863235
PTEN, KLLNnot providedUncertain significance
(Jan 3, 2014)
criteria provided, single submitterVCV000189526
41.
GRCh37:
Chr10:89623000
GRCh38:
Chr10:87863243
PTEN, KLLNnot providedUncertain significance
(Sep 29, 2016)
criteria provided, single submitterVCV000488867
42.
GRCh37:
Chr10:89623002
GRCh38:
Chr10:87863245
PTEN, KLLNnot providedUncertain significance
(Oct 17, 2017)
criteria provided, single submitterVCV000488868
43.
GRCh37:
Chr10:89623004
GRCh38:
Chr10:87863247
PTEN, KLLNnot providedUncertain significance
(Apr 4, 2018)
criteria provided, single submitterVCV000488935
44.
GRCh37:
Chr10:89623005
GRCh38:
Chr10:87863248
PTEN, KLLNnot providedUncertain significance
(Nov 9, 2016)
criteria provided, single submitterVCV000488954
45.
GRCh37:
Chr10:89623005
GRCh38:
Chr10:87863248
PTEN, KLLNnot providedUncertain significance
(Dec 1, 2017)
criteria provided, single submitterVCV000488773
46.
GRCh37:
Chr10:89623010
GRCh38:
Chr10:87863253
KLLN, PTENHereditary cancer-predisposing syndromeUncertain significance
(Oct 30, 2014)
criteria provided, single submitterVCV000186991
47.
GRCh37:
Chr10:89623012
GRCh38:
Chr10:87863255
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Apr 2, 2014)
criteria provided, single submitterVCV000142999
48.
GRCh37:
Chr10:89623014
GRCh38:
Chr10:87863257
PTEN, KLLNnot providedUncertain significance
(Oct 27, 2017)
criteria provided, multiple submitters, no conflictsVCV000488850
49.
GRCh37:
Chr10:89623016
GRCh38:
Chr10:87863259
PTEN, KLLNnot providedUncertain significance
(Aug 11, 2017)
criteria provided, single submitterVCV000189521
50.
GRCh37:
Chr10:89623018
GRCh38:
Chr10:87863261
PTEN, KLLNnot providedUncertain significance
(Apr 21, 2014)
criteria provided, single submitterVCV000189469
51.
GRCh37:
Chr10:89623019
GRCh38:
Chr10:87863262
PTEN, KLLNnot providedUncertain significance
(Feb 16, 2016)
criteria provided, single submitterVCV000234396
52.
GRCh37:
Chr10:89623020
GRCh38:
Chr10:87863263
PTEN, KLLNnot providedUncertain significance
(May 11, 2015)
criteria provided, single submitterVCV000488714
53.
GRCh37:
Chr10:89623021
GRCh38:
Chr10:87863264
PTEN, KLLNnot providedUncertain significance
(Jul 10, 2017)
criteria provided, single submitterVCV000488715
54.
GRCh37:
Chr10:89623024
GRCh38:
Chr10:87863267
PTEN, KLLNnot providedUncertain significance
(Nov 29, 2017)
criteria provided, single submitterVCV000234473
55.
GRCh37:
Chr10:89623031-89623042
GRCh38:
Chr10:87863273-87863284
PTEN, KLLNHereditary cancer-predisposing syndrome, PTEN hamartoma tumor syndrome, not provided
Likely benign
(Mar 5, 2019)
reviewed by expert panel
FDA Recognized Database
VCV000189433
56.
GRCh37:
Chr10:89623034
GRCh38:
Chr10:87863277
PTEN, KLLNnot providedUncertain significance
(Apr 25, 2016)
criteria provided, single submitterVCV000488900
57.
GRCh37:
Chr10:89623036
GRCh38:
Chr10:87863279
PTEN, KLLNMacrocephaly/autism syndrome, VACTERL association with hydrocephalus, Meningioma, familial,
PTEN hamartoma tumor syndrome, Cowden syndrome 1, Glioma susceptibility 2,
Malignant tumor of prostate, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Oct 31, 2018)
criteria provided, multiple submitters, no conflictsVCV000127663
58.
GRCh37:
Chr10:89623039-89623041
GRCh38:
Chr10:87863282-87863284
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Apr 26, 2014)
criteria provided, single submitterVCV000142982
59.
GRCh37:
Chr10:89623045
GRCh38:
Chr10:87863288
PTEN, KLLNnot providedUncertain significance
(Dec 23, 2017)
criteria provided, multiple submitters, no conflictsVCV000488716
60.
GRCh37:
Chr10:89623047-89623048
GRCh38:
Chr10:87863290-87863291
PTEN, KLLNnot providedUncertain significance
(Aug 29, 2016)
criteria provided, single submitterVCV000503748
61.
GRCh37:
Chr10:89623047
GRCh38:
Chr10:87863290
PTEN, KLLNnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(May 7, 2018)
criteria provided, multiple submitters, no conflictsVCV000142652
62.
GRCh37:
Chr10:89623050
GRCh38:
Chr10:87863293
PTEN, KLLNnot provided, Hereditary cancer-predisposing syndrome, Cowden syndrome 1
Uncertain significance
(Feb 13, 2018)
criteria provided, multiple submitters, no conflictsVCV000142844
63.
GRCh37:
Chr10:89623052
GRCh38:
Chr10:87863295
PTEN, KLLNnot providedUncertain significance
(Sep 19, 2016)
criteria provided, single submitterVCV000488939
64.
GRCh37:
Chr10:89623053
GRCh38:
Chr10:87863296
PTEN, KLLNnot providedUncertain significance
(Mar 7, 2016)
criteria provided, single submitterVCV000488866
65.
GRCh37:
Chr10:89623054
GRCh38:
Chr10:87863297
PTEN, KLLNnot providedUncertain significance
(Jan 3, 2017)
criteria provided, single submitterVCV000488786
66.
GRCh37:
Chr10:89623054
GRCh38:
Chr10:87863297
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Jan 16, 2014)
criteria provided, single submitterVCV000141170
67.
GRCh37:
Chr10:89623056
GRCh38:
Chr10:87863299
PTEN, KLLNHereditary cancer-predisposing syndrome, Cowden syndrome 1, not provided
Uncertain significance
(Jul 5, 2018)
criteria provided, multiple submitters, no conflictsVCV000140783
68.
GRCh37:
Chr10:89623056
GRCh38:
Chr10:87863299
PTEN, KLLNCowden syndrome 1, PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome,
not provided
Uncertain significance
(Nov 8, 2017)
reviewed by expert panel
FDA Recognized Database
VCV000127662
69.
GRCh37:
Chr10:89623072
GRCh38:
Chr10:87863315
PTEN, KLLNMeningioma, familial, VACTERL association with hydrocephalus, PTEN hamartoma tumor syndrome,
Glioma susceptibility 2, Cowden syndrome 1, Malignant tumor of prostate,
Macrocephaly/autism syndrome, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Oct 31, 2018)
criteria provided, multiple submitters, no conflictsVCV000187362
70.
GRCh37:
Chr10:89623073
GRCh38:
Chr10:87863316
PTEN, KLLNnot providedUncertain significance
(Feb 17, 2017)
criteria provided, single submitterVCV000488717
71.
GRCh37:
Chr10:89623081
GRCh38:
Chr10:87863324
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(May 13, 2016)
criteria provided, single submitterVCV000187000
72.
GRCh37:
Chr10:89623082
GRCh38:
Chr10:87863325
PTEN, KLLNnot providedUncertain significance
(Nov 11, 2016)
criteria provided, single submitterVCV000234900
73.
GRCh37:
Chr10:89623083
GRCh38:
Chr10:87863326
PTEN, KLLNnot providedUncertain significance
(Mar 10, 2016)
criteria provided, single submitterVCV000488748
74.
GRCh37:
Chr10:89623084
GRCh38:
Chr10:87863327
PTEN, KLLNnot providedUncertain significance
(Mar 16, 2018)
criteria provided, single submitterVCV000234867
75.
GRCh37:
Chr10:89623084
GRCh38:
Chr10:87863327
PTEN, KLLNPTEN hamartoma tumor syndrome, not provided, not specified,
Hereditary cancer-predisposing syndrome
Likely benign
(Apr 6, 2018)
reviewed by expert panel
FDA Recognized Database
VCV000127661
76.
GRCh37:
Chr10:89623086-89623087
GRCh38:
Chr10:87863329-87863330
PTEN, KLLNnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(Nov 20, 2015)
criteria provided, multiple submitters, no conflictsVCV000234632
77.
GRCh37:
Chr10:89623088
GRCh38:
Chr10:87863331
PTEN, KLLNnot providedUncertain significance
(Apr 10, 2015)
criteria provided, single submitterVCV000488755
78.
GRCh37:
Chr10:89623089
GRCh38:
Chr10:87863332
PTEN, KLLNnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(Mar 7, 2018)
criteria provided, multiple submitters, no conflictsVCV000141864
79.
GRCh37:
Chr10:89623090
GRCh38:
Chr10:87863333
PTEN, KLLNnot providedUncertain significance
(Sep 9, 2016)
criteria provided, single submitterVCV000488938
80.
GRCh37:
Chr10:89623091-89623092
GRCh38:
Chr10:87863334-87863335
KLLN, PTENHereditary cancer-predisposing syndromeUncertain significance
(Aug 6, 2014)
criteria provided, single submitterVCV000189434
81.
GRCh37:
Chr10:89623093
GRCh38:
Chr10:87863336
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Mar 26, 2014)
criteria provided, single submitterVCV000142892
82.
GRCh37:
Chr10:89623096
GRCh38:
Chr10:87863339
PTEN, KLLNnot providedUncertain significance
(Jun 10, 2015)
criteria provided, single submitterVCV000503509
83.
GRCh37:
Chr10:89623104
GRCh38:
Chr10:87863347
PTEN, KLLNnot providedUncertain significance
(Jun 30, 2016)
criteria provided, single submitterVCV000488922
84.
GRCh37:
Chr10:89623105
GRCh38:
Chr10:87863348
PTEN, KLLNnot providedUncertain significance
(Dec 11, 2015)
criteria provided, single submitterVCV000234686
85.
GRCh37:
Chr10:89623106
GRCh38:
Chr10:87863349
PTEN, KLLNnot provided, not specifiedUncertain significance
(Dec 11, 2017)
criteria provided, multiple submitters, no conflictsVCV000503505
86.
GRCh37:
Chr10:89623114
GRCh38:
Chr10:87863357
PTEN, KLLNnot providedUncertain significance
(Jul 30, 2018)
criteria provided, multiple submitters, no conflictsVCV000503511
87.
GRCh37:
Chr10:89623117
GRCh38:
Chr10:87863360
PTEN, KLLNnot providedUncertain significance
(Aug 8, 2016)
criteria provided, single submitterVCV000488930
88.
GRCh37:
Chr10:89623126
GRCh38:
Chr10:87863369
PTEN, KLLNnot providedUncertain significance
(Aug 31, 2017)
criteria provided, single submitterVCV000488885
89.
GRCh37:
Chr10:89623126
GRCh38:
Chr10:87863369
PTEN, KLLNnot providedUncertain significance
(Oct 14, 2015)
criteria provided, single submitterVCV000488791
90.
GRCh37:
Chr10:89623128
GRCh38:
Chr10:87863371
PTEN, KLLNnot specifiedUncertain significance
(Jul 12, 2016)
criteria provided, single submitterVCV000418430
91.
GRCh37:
Chr10:89623130
GRCh38:
Chr10:87863373
PTEN, KLLNnot providedUncertain significance
(Aug 20, 2014)
criteria provided, single submitterVCV000189470
92.
GRCh37:
Chr10:89623131
GRCh38:
Chr10:87863374
PTEN, KLLNCowden syndrome 1Uncertain significance
(Dec 9, 2017)
criteria provided, single submitterVCV000548816
93.
GRCh37:
Chr10:89623131
GRCh38:
Chr10:87863374
PTEN, KLLNnot providedUncertain significance
(Oct 10, 2016)
criteria provided, single submitterVCV000189471
94.
GRCh37:
Chr10:89623139-89623164
GRCh38:
Chr10:87863382-87863407
PTEN, KLLNHereditary cancer-predisposing syndrome, not providedUncertain significance
(Mar 13, 2018)
criteria provided, multiple submitters, no conflictsVCV000189435
95.
GRCh37:
Chr10:89623141
GRCh38:
Chr10:87863384
PTEN, KLLNPTEN hamartoma tumor syndromeBenign
(Nov 5, 2015)
criteria provided, single submitterVCV000224942
96.
GRCh37:
Chr10:89623142
GRCh38:
Chr10:87863385
PTEN, KLLNnot providedUncertain significance
(Sep 18, 2015)
criteria provided, single submitterVCV000488788
97.
GRCh37:
Chr10:89623142
GRCh38:
Chr10:87863385
PTEN, KLLNPTEN hamartoma tumor syndrome, Cowden syndrome 1, not specified,
not provided, Hereditary cancer-predisposing syndrome
Likely benign
(Nov 28, 2018)
reviewed by expert panel
FDA Recognized Database
VCV000127660
98.
GRCh37:
Chr10:89623143
GRCh38:
Chr10:87863386
PTEN, KLLNnot providedUncertain significance
(Nov 19, 2018)
criteria provided, single submitterVCV000488921
99.
GRCh37:
Chr10:89623143
GRCh38:
Chr10:87863386
PTEN, KLLNHereditary cancer-predisposing syndromeUncertain significance
(Dec 13, 2013)
criteria provided, single submitterVCV000142058
100.
GRCh37:
Chr10:89623146
GRCh38:
Chr10:87863389
PTEN, KLLNHereditary cancer-predisposing syndrome, not providedUncertain significance
(Dec 13, 2017)
criteria provided, multiple submitters, no conflictsVCV000141604
Format
Items per page
Sort by

Download:

Choose Destination
Support Center